Messoud Ashina is a renowned Danish neuroscientist and the director of the Human Migraine Research Unit at the Danish Headache Center. He is a Professor of Neurology and Chief Physician at the Department of Neurology, Rigshospitalet, Faculty of Medical and Health Sciences, University of Copenhagen. Dr. Ashina has been involved in research on headache pathophysiology since 1995, focusing on experimental headache and migraine models and neuroimaging studies of trigeminovascular pain mechanisms. He finished his PhD and DMSc degrees in 2000 and 2003 on the mechanisms of tension-type headache. Since then, he has expanded his focus to include migraine and cluster headache as well.

Faisal Amin is a medical doctor, postdoctoral researcher and associate professor at the Danish Headache Center. Over the past 10 years, Dr. Amin has conducted extensive clinical research in developing advanced magnetic resonance imaging models to investigate structural and functional biomarkers of migraine. Today, Dr. Amin has expanded his interest to include post-traumatic headache; thus, paving the way for precision medicine in post-traumatic diagnostics.

Anders Hougaard is a medical doctor and postdoctoral researcher at the Danish Headache Center. Dr. Hougaard has been active in clinical headache research since 2009 and completed his PhD in Neuroscience on the topic of advanced magnetic resonance imaging investigations in migraine with aura in 2014. His current main research interests include the pathophysiology of migraine (in particular migraine aura), neuroimaging methods in headache, and headache trigger factors.

Marie Deen is a medical doctor and postdoctoral researcher at the Danish Headache Center. Dr. Deen has been active in clinical headache research since 2014 and completed her PhD in Neuroscience, investigating the role of serotonin in migraine pathophysiology using PET imaging, in 2019. Her current main research interests include the pathophysiology of migraine, more specifically the role of serotonin, neuroimaging methods in headache, and headache trigger factors. She has also been involved in several clinical trials investigating the migraine preventive effect of anti-calcitonin gene-related peptide receptor antibodies.

Sabrina Khan is a medical doctor and postdoctoral researcher at the Danish Headache Center. Dr. Khan has been active in clinical headache research since 2012 and completed her PhD in Clinical Research, investigating the pathophysiology of migraine without aura in human experimental models using MR imaging, in 2019. Her current main research interests include neuroimaging methods in headache, specifially the usability and prospect of iron-oxide nanoparticles, human experimental models, and headache trigger factors. Dr. Khan has also been involved in the conductance of clinical trials investigating the migraine preventive effect of anti-calcitonin gene-related peptide receptor antibodies.

Song Guo is a medical doctor and postdoctoral researcher at the Danish Headache Center. Dr. Guo has been active in clinical headache research since 2008 and completed his PhD in Neuroscience on the role of genetics on migraine induction triggered by calcitonin gene-related peptide and pituitary adenylate cyclase-activating peptide 38 in 2016. His current main research interests include the experimental human models of migraine and cluster headache, neurostimulation therapies and migraine genetics. He has also been involved in several clinical trials e.g. Pulsante and Aimovig.

Nanna Arngrim is a medical doctor and postdoctoral researcher at the Danish Headache Center. Dr. Arngrim has been active in clinical headache research since 2012 and completed her PhD in Clinical Research, investigating the pathophysiology of migraine with aura in a human experimental hypoxia model using MR imaging, in 2018. Her current main research interests include neuroimaging methods in headache, human experimental models, and headache trigger factors. Dr. Arngrim has also been involved in the conductance of clinical trials investigating the migraine preventive effect of anti-calcitonin gene-related peptide receptor antibodies.

Anne Luise Vollesen is a medical doctor and began working in the field of headache research as a medical student in 2014 investigating migraine induction mechanisms of pituitary adenylate cyclase-activating peptide. She continued on to expand her field of research into experimental induction of cluster headache also using pharmacological triggers which is now her main research focus. She has also worked on several clinical trials investigating migraine prevention using monoclonal antibodies.

Samaira Younis is a medical doctor and has been active in clinical headache research since 2014. She has been affiliated with the Danish Headache Center since she was a medical student and is currently enrolled in the Neuroscience PhD program. Her field of research involves investigation of pain mechanisms in migraine using neuroimaging and experimental human migraine models. Dr. Younis has also been involved in several clinical trials investigating migraine preventive effects of monoclonal antibodies.

Casper Emil Christensen has been involved in headache research with since 2013. He started as a medical student and continued into a PhD program focusing on the pathophysiology of migraine and neuroimaging. He is currently working on magnetic resonance imaging investigations in human provocation models with a special interest in pain mechanisms in migraine without aura. Dr. Christensen has also been involved in clinical trials investigating migraine prevention with monoclonal antibodies.

Hashmat Ghanizada is a medical doctor and interested in understanding neuropeptides interaction in pathophysiology of migraine using novel human experimental models. He is also interested in identifying non-trigeminal biomarkers of migraine to aid in prognostic and diagnostic ability at the clinic. Dr. Ghanizada has previously worked at the Neural Plasticity Lab, Department of Neuroscience and Pharmacology, University of Copenhagen. He joined headache research at Danish Headache Center in 2016 with primary focus on conducting clinical trials investigating migraine prevention with anti-CGRP/receptor and anti-PAC1 receptor monoclonal antibodies.

Mohammad Al-Mahdi Al-Karagholi is a medical doctor with a research interest in therapeutic novelties in migraine. In the last three years, he has been studying the role of ATP sensitive potassium channels in migraine pathophysiology in migraine with and without aura patients. He has also been involved in clinical trials investigating migraine prevention with monoclonal antibodies.

Nita Katarina Frifelt Wienholtz is a medical doctor has worked at the Danish Headache Center since 2017 and is enrolled in the Neuroscience PhD program. She is interested in understanding the relationship between migraine and rosacea and is conducting semi-structured interviews along with experimental induction of headache and flushing in humans. Her project is a collaboration with the Department of Dermatology. She has also been involved in clinical trials investigating migraine prevention using monoclonal antibodies.

Thien Phu Do is a medical doctor with a research interest in therapeutic novelties in migraine. He has previously done research at the Headache Diagnostic Laboratory at the Danish Headache Center e.g. phenotyping of patients with headache disorders. Dr. Do is now investigating the effect of anti-calcitonin gene-related peptide (receptor) monoclonal antibodies on neurovascular signaling pathways in human provocation models. He is also involved in clinical trials with new migraine medication.

Lanfranco Pellesi is a medical doctor specialized in clinical pharmacology. He has previously worked at an Italian headache center for three years, conducting care activities and scientific research. His main interests are chronic headaches, medication overuse headache and their pathophysiological mechanisms. Dr. Pellesi is currently investigating the effects of vasoactive intestinal polypeptide in healthy subjects and in patients with migraine.